The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapySite-Specific Drug-Releasing Polypeptide Nanocarriers Based on Dual-pH Response for Enhanced Therapeutic Efficacy against Drug-Resistant Tumors.Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck.Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
P2860
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The combined use of paclitaxel ...... in to overcome drug resistance
@ast
The combined use of paclitaxel ...... in to overcome drug resistance
@en
type
label
The combined use of paclitaxel ...... in to overcome drug resistance
@ast
The combined use of paclitaxel ...... in to overcome drug resistance
@en
prefLabel
The combined use of paclitaxel ...... in to overcome drug resistance
@ast
The combined use of paclitaxel ...... in to overcome drug resistance
@en
P2093
P2860
P356
P1476
The combined use of paclitaxel ...... in to overcome drug resistance
@en
P2093
Chung Ping Leon Wan
Helen M Burt
John K Jackson
Kevin Letchford
P2860
P304
P356
10.2147/IJN.S38737
P407
P577
2013-01-22T00:00:00Z